Emergence companies gain access to a range of education, training and investment capital opportunities
Charlottetown, PE – Emergence, Atlantic Canada’s bioscience business incubator and Keiretsu Forum Canada (Keiretsu) have entered into an agreement, making Emergence an official Network Partner of Keiretsu.
Under this agreement, Keiretsu will provide access and support from their global investor network as well as a range of education and training opportunities to both Emergence companies and the Emergence mentor team. Keiretsu will also provide Emergence companies with a potential source of investment capital, should they be accepted, while Emergence will provide Keiretsu with access to the latest high potential bioscience companies.
Emergence is Atlantic Canada’s bioscience business incubator dedicated to assisting start-ups and growth-stage companies in efficiently bringing their products and services to market. Emergence provides companies with business incubation services including mentorship and advisory services, team mentorship program as well as access to networks and resources. Emergence has more than 50 client companies from across the region in the incubator program and in 2019, these companies raised more than $200 million in capital.
“We are very pleased to partner with Keiretsu to offer this added benefit to both the companies in the incubator as well as our mentors,” said Jason Cleaversmith, Executive Director, Incubation and Infrastructure, PEI BioAlliance. “This partnership will elevate our service offering and continue to support bioscience companies in the region to thrive.”
Established in 2012, Keiretsu Forum brings together its investor members with the best investment opportunities in emerging companies from around the globe. Keiretsu Forum is the fastest growing, largest, and most active angel community in the world. It is the largest global investment network with over 50+ chapters and over 3,000 accredited private equity investors, venture capitalists, family offices and corporate/institutional investors.
“What makes Keiretsu Forum unique are partnerships such as these with the PEI-based Emergence Incubator,” said Ozan Isinak, President, Keiretsu Forum Canada. “This will clear the path for bioscience companies in Atlantic Canada to access a globally competitive early-stage eco-system while allowing our active investor base and our portfolio companies to diversify into new geographies. We look forward to building a deep relationship with the regional community.”